Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02943187
Other study ID # GICR-1012
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 2016
Est. completion date June 2022

Study information

Verified date July 2021
Source Gibson Institute of Cognitive Research
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this investigation is to conduct a series of case studies on the impact of a novel functional medicine approach to improving cognitive skills, brain structure, and daily functioning for participants with Mild Cognitive Impairment (MCI).


Description:

Using a multiple baseline design across cases with start point randomization, the proposed study will examine the outcomes from a combination of optimized diet, exercise, nutritional supplements, and cognitive training across domains on standardized measures used to monitor treatment effectiveness for Mild Cognitive Impairment (MCI).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 5
Est. completion date June 2022
Est. primary completion date December 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years to 75 Years
Eligibility Inclusion Criteria: - Age 50+ previously diagnosed with MCI - Living in the greater Colorado Springs area Exclusion Criteria: - No braces, metal implants, or claustrophobia that would contraindicate magnetic resonance imaging

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive training
A clinician will deliver three 90-minute cognitive training sessions per week for 14 weeks. There are 16 different categories of leveled training procedures sequenced in intensity and difficulty for a total of 530 training tasks.
Dietary Supplement:
Nutrition
Participants will be given dietary recommendations and nutritional supplements to optimize cognition.

Locations

Country Name City State
United States Gibson Institute of Cognitive Research Colorado Springs Colorado

Sponsors (2)

Lead Sponsor Collaborator
Gibson Institute of Cognitive Research True Life Medicine

Country where clinical trial is conducted

United States, 

References & Publications (1)

James, R., Moore, A.L., Carpenter, D., Miller, T., & Ledbetter, C. (2019). Feasibility of a Functional Medicine Approach to Slowing Clinical Cognitive Decline in Patients Over Age 55: A Multiple Case Study Report. OBM Integrative and Complementary Medicin

Outcome

Type Measure Description Time frame Safety issue
Primary Evidence of overall cognitive function improvement Confirmed by change in pretest to post-test scores on the Dementia Rating Scale (DRS-2) within 14 days after completing the intervention
Secondary Evidence of improvement in executive function As confirmed by pretest to post-test changes on the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) within 14 days after completing the intervention
Secondary Evidence of improvement in cognitive flexibility As confirmed by pretest to post-test changes on a Trail Making Test within 14 days after completing the intervention
Secondary Evidence of change in brain function Confirmed by change in pretest to post-test neuroimaging using MRI within 30 days after completing the intervention
Secondary Evidence of improvement in visual attention Confirmed by change in pretest to post-test scores on the Conners Continous Performance Test (CPT-3) with 14 days after completing the intervention
Secondary Evidence of improvement in auditory attention Confirmed by change in pretest to post-test scores on the Auditory Attention Test (CATA) with 14 days after completing the intervention
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A

External Links